English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 27, 2026

FARE releases national report detailing prevalence and impact of food allergies
+ Pharmaceuticals
Patient Daily | Feb 27, 2026

FARE partners with Alpha-gal Alliance to boost awareness of tick-related food allergy
+ Pharmaceuticals
Patient Daily | Feb 27, 2026

Body contouring at Ohio State: evaluation process and considerations for candidates
+ Pharmaceuticals
Patient Daily | Feb 27, 2026

Rare disease groups urge faster approvals amid stricter FDA scrutiny
+ Pharmaceuticals
Patient Daily | Feb 26, 2026

New study identifies multiple paths for therapy resistance in triple-negative breast cancer
+ Pharmaceuticals
Patient Daily | Feb 26, 2026

FDA shifts stance on drug approvals with move toward single pivotal trial
+ Pharmaceuticals
Patient Daily | Feb 26, 2026

Atara stock rises after report questions FDA’s rejection of cell therapy
+ Pharmaceuticals
Patient Daily | Feb 26, 2026

PRI President Pipes on 340B drug pricing: ‘Patients ultimately pay the price’

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes